MORANDI, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 4.800
EU - Europa 3.557
AS - Asia 2.422
SA - Sud America 348
Continente sconosciuto - Info sul continente non disponibili 116
AF - Africa 61
OC - Oceania 18
Totale 11.322
Nazione #
US - Stati Uniti d'America 4.695
PL - Polonia 1.045
RU - Federazione Russa 891
IT - Italia 857
SG - Singapore 711
CN - Cina 619
HK - Hong Kong 335
BR - Brasile 267
VN - Vietnam 248
KR - Corea 177
IE - Irlanda 157
SE - Svezia 147
BD - Bangladesh 102
FR - Francia 100
FI - Finlandia 99
DE - Germania 72
CA - Canada 59
IN - India 49
GB - Regno Unito 47
ID - Indonesia 41
ES - Italia 37
NL - Olanda 35
JO - Giordania 28
AR - Argentina 27
EC - Ecuador 20
UA - Ucraina 19
AU - Australia 17
JP - Giappone 16
MX - Messico 15
CH - Svizzera 14
IQ - Iraq 14
TR - Turchia 14
ZA - Sudafrica 14
BE - Belgio 11
CI - Costa d'Avorio 11
CO - Colombia 11
AE - Emirati Arabi Uniti 10
PK - Pakistan 10
MY - Malesia 9
NG - Nigeria 8
CR - Costa Rica 7
MA - Marocco 7
TW - Taiwan 7
CL - Cile 6
TT - Trinidad e Tobago 6
UY - Uruguay 6
AT - Austria 5
AZ - Azerbaigian 5
GR - Grecia 5
VE - Venezuela 5
BJ - Benin 4
DZ - Algeria 4
EG - Egitto 4
HN - Honduras 4
PY - Paraguay 4
SA - Arabia Saudita 4
AL - Albania 3
GT - Guatemala 3
IL - Israele 3
JM - Giamaica 3
KE - Kenya 3
LB - Libano 3
PA - Panama 3
BG - Bulgaria 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
KW - Kuwait 2
KZ - Kazakistan 2
NI - Nicaragua 2
NP - Nepal 2
PH - Filippine 2
PR - Porto Rico 2
PT - Portogallo 2
RO - Romania 2
SN - Senegal 2
TH - Thailandia 2
TN - Tunisia 2
UZ - Uzbekistan 2
AO - Angola 1
BO - Bolivia 1
CY - Cipro 1
EU - Europa 1
GL - Groenlandia 1
KG - Kirghizistan 1
KI - Kiribati 1
LT - Lituania 1
LV - Lettonia 1
MM - Myanmar 1
PE - Perù 1
PS - Palestinian Territory 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
ZW - Zimbabwe 1
Totale 11.207
Città #
Warsaw 1.040
Santa Clara 851
Ashburn 640
Singapore 546
Fairfield 453
Hong Kong 296
San Jose 251
Woodbridge 199
Seattle 189
Houston 187
Seoul 170
Cambridge 166
Dublin 156
Milan 144
Florence 139
Hefei 138
Chandler 134
Wilmington 130
Beijing 126
Council Bluffs 101
Ann Arbor 90
Ho Chi Minh City 84
Altamura 69
Lawrence 69
Helsinki 65
Los Angeles 64
Lauterbourg 49
Buffalo 47
Rome 45
Hanoi 44
Princeton 43
The Dalles 42
São Paulo 35
Jakarta 34
Moscow 34
New York 34
Shanghai 31
Medford 30
Paris 28
Phoenix 28
Chicago 27
Dong Ket 27
Clifton 26
San Diego 26
Kent 25
Boardman 24
Dallas 23
Mumbai 23
Munich 23
Boston 22
Naples 22
Barcelona 18
Toronto 18
Melbourne 17
Frankfurt am Main 15
Tokyo 15
Turin 15
Da Nang 13
Jacksonville 13
Lappeenranta 13
London 13
Orem 13
Bern 12
Bologna 12
Brasília 12
Brooklyn 12
Falls Church 12
Abidjan 11
Brussels 11
Figino 11
Tianjin 11
Belo Horizonte 9
Redondo Beach 9
Stockholm 9
Yubileyny 9
Amman 8
Bengaluru 8
Chieri 8
Hangzhou 8
Montreal 8
Nuremberg 8
Turku 8
Abuja 7
Baghdad 7
Guangzhou 7
Johannesburg 7
Padua 7
Quito 7
San Francisco 7
Can Tho 6
Denver 6
Donostia / San Sebastian 6
Guayaquil 6
Hải Dương 6
Istanbul 6
Miano 6
Newark 6
Ribeirão Preto 6
Amsterdam 5
Baku 5
Totale 7.761
Nome #
The Colony-Stimulating Factor-1 (CSF-1) Receptor Sustains ERK1/2 Activation and Proliferation in Breast Cancer Cell Lines. 381
Zoledronic acid impairs stromal reactivity by inhibiting M2-macrophages polarization and prostate cancer-associated fibroblasts. 369
Cancer-associated fibroblasts promote prostate cancer malignancy via metabolic rewiring and mitochondrial transfer 352
Chromatin-associated CSF-1R binds to the promoter of proliferation-related genes in breast cancer cells. 348
Metabolic shift toward oxidative phosphorylation in docetaxel resistant prostate cancer cells. 343
Reprogramming of Amino Acid Transporters to Support Aspartate and Glutamate Dependency Sustains Endocrine Resistance in Breast Cancer 323
The metabolic gene HAO2 is downregulated in hepatocellular carcinoma and predicts metastasis and poor survival 307
Mesenchymal to amoeboid transition is associated with stem-like features of melanoma cells 291
Targeting stromal-induced pyruvate kinase M2 nuclear translocation impairs OXPHOS and prostate cancer metastatic spread 275
Glucose Metabolic Reprogramming of ER Breast Cancer in Acquired Resistance to the CDK4/6 Inhibitor Palbociclib 266
Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancer 263
Targeting the receptor tyrosine kinase RET in combination with aromatase inhibitors in ER positive breast cancer xenografts 239
Down-Regulation of SOX2 Underlies the Inhibitory Effects of the Triphenylmethane Gentian Violet on Melanoma Cell Self-Renewal and Survival 235
Lactate modulates CD4 + T-cell polarization and induces an immunosuppressive environment, which sustains prostate carcinoma progression via TLR8/miR21 axis 226
Fat and Furious: Lipid Metabolism in Antitumoral Therapy Response and Resistance 220
Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis 213
Stromal-induced downregulation of miR-1247 promotes prostate cancer malignancy 211
miR-155 Drives Metabolic Reprogramming of ER+ Breast Cancer Cells Following Long-Term Estrogen Deprivation and Predicts Clinical Response to Aromatase Inhibitors. 211
Lactate supports cell-autonomous ECM production to sustain metastatic behavior in prostate cancer 210
Selective anti-leukaemic activity of low-dose histone deacetylase inhibitor ITF2357 on AML1/ETO-positive cells 206
Targeting the Metabolic Reprogramming That Controls Epithelial-to-Mesenchymal Transition in Aggressive Tumors 200
Senescent stroma promotes prostate cancer progression: The role of miR-210 192
Signaling pathways regulating redox balance in cancer metabolism 191
International multidisciplinary consensus on the integration of radiotherapy with new systemic treatments for breast cancer: European Society for Radiotherapy and Oncology (ESTRO)-endorsed recommendations 189
ERK5/BMK1 is indispensable for optimal colony-stimulating factor 1 (CSF-1)-induced proliferation in macrophages in a Src-dependent fashion. 188
Linking metabolic reprogramming to therapy resistance in cancer 185
Integrating radiation therapy with targeted treatments for breast cancer: From bench to bedside 183
Lactate: A Metabolic Driver in the Tumour Landscape 183
Acetyl-CoA carboxylase 1 controls a lipid droplet-peroxisome axis and is a vulnerability of endocrine-resistant ER+ breast cancer 182
Metabolic reprogramming in Nrf2-driven proliferation of normal rat hepatocytes 179
Lysosomal lipid switch sensitises to nutrient deprivation and mTOR targeting in pancreatic cancer 174
FADS1/2 control lipid metabolism and ferroptosis susceptibility in triple-negative breast cancer 173
Essential requirements for reporting radiation therapy in breast cancer clinical trials: An international multi-disciplinary consensus endorsed by the European Society for Radiotherapy and Oncology (ESTRO) 167
Safety profile of trastuzumab-emtansine (T-DM1) with concurrent radiation therapy: a systematic review and meta-analysis 166
Lactate rewires lipid metabolism and sustains a metabolic-epigenetic axis in prostate cancer 166
Succinate dehydrogenase subunit B mutations modify human neuroblastoma cell metabolism and proliferation 165
GDNF-RET signaling in ER-positive breast cancers is a key determinant of response and resistance to aromatase inhibitors 163
Safety of CDK4/6 inhibitors and concomitant radiation therapy in patients affected by metastatic breast cancer 160
Focal adhesion kinase (FAK) binds RET kinase via its FERM domain, priming a direct and reciprocal RET-FAK transactivation mechanism 160
Targeting RET-interleukin-6 crosstalk to impair metastatic dissemination in breast cancer 159
Expression of activated VEGFR2 by R1051Q mutation alters the energy metabolism of Sk-Mel-31 melanoma cells by increasing glutamine dependence 159
Sex difference in liver diseases: How preclinical models help to dissect the sex-related mechanisms sustaining NAFLD and hepatocellular carcinoma 157
Metabolic implication of tumor:stroma crosstalk in breast cancer. 157
RET in breast cancer: functional and therapeutic implications 156
Nutrient Exploitation within the Tumor–Stroma Metabolic Crosstalk 155
Thyroid hormone inhibits hepatocellular carcinoma progression via induction of differentiation and metabolic reprogramming 151
In vivo imaging of the spatial heterogeneity of intratumoral acidosis (pH) as a marker of the metastatic phenotype in breast cancer 145
A novel phage display based platform for exosome diversity characterization 140
Ponatinib is a potent inhibitor of wild-type and drug-resistant gatekeeper mutant RET kinase 126
CD44 and SLC1A2 are commonly regulated but do not form a fusion transcript in ER+ breast cancer 125
Oxidative phosphorylation is a metabolic vulnerability of endocrine therapy and palbociclib resistant metastatic breast cancers 121
Targeting the receptor tyrosine kinase RET sensitizes breast cancer cells to tamoxifen treatment and reveals a role for RET in endocrine resistance 113
Safety profile of cyclin-dependent kinase (CDK) 4/6 inhibitors with concurrent radiation therapy: A systematic review and meta-analysis 100
Cardioprotection in patients with anthracycline-treated breast cancer: final analysis from the 2 × 2 randomized, placebo-controlled, double-blind SAFE trial 99
Estrogen-dependent activation of TRX2 reverses oxidative stress and metabolic dysfunction associated with steatotic disease 94
Targeting carbonic anhydrase IX/XII prevents the anti-ferroptotic effect of stromal lactic acid in prostate carcinoma 88
MAPK15 controls intracellular lipid uptake and protects mammalian liver from steatotic disease 70
ESR1 Activating Mutations Confer Metabolic Vulnerabilities in ER+ Breast Cancer 63
Lead induces cell-autonomous proliferation and metabolic reprogramming of hepatocytes 53
Cell Cycle Control of Nuclear Metabolism Couples Phosphatidylinositol Signaling to Histone Methylation 20
Under pressure: peroxisomes in cancer therapy resistance 16
Totale 11.322
Categoria #
all - tutte 30.496
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.496


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022314 0 0 36 14 20 11 20 42 11 32 40 88
2022/2023778 62 190 44 41 49 137 96 35 69 9 27 19
2023/2024402 16 35 49 15 31 23 20 102 28 22 31 30
2024/20252.606 84 234 153 383 695 365 64 191 111 76 100 150
2025/20263.773 343 446 354 359 450 131 474 184 201 252 186 393
2026/2027553 171 180 202 0 0 0 0 0 0 0 0 0
Totale 11.322